Renaissance Technologies’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.6M | Sell |
2,055,340
-107,300
| -5% | -$501K | 0.01% | 1077 |
|
|
2025
Q1 | $11.9M | Buy |
2,162,640
+63,800
| +3% | +$350K | 0.02% | 917 |
|
|
2024
Q4 | $7.12M | Buy |
2,098,840
+500,120
| +31% | +$1.7M | 0.01% | 1224 |
|
|
2024
Q3 | $4.56M | Buy |
1,598,720
+247,080
| +18% | +$704K | 0.01% | 1506 |
|
|
2024
Q2 | $3.04M | Buy |
1,351,640
+342,300
| +34% | +$770K | 0.01% | 1604 |
|
|
2024
Q1 | $2.23M | Sell |
1,009,340
-372,300
| -27% | -$823K | ﹤0.01% | 1960 |
|
|
2023
Q4 | $3.25M | Buy |
1,381,640
+359,600
| +35% | +$845K | 0.01% | 1630 |
|
|
2023
Q3 | $1.9M | Buy |
1,022,040
+163,346
| +19% | +$304K | ﹤0.01% | 1899 |
|
|
2023
Q2 | $2.25M | Buy |
858,694
+254,800
| +42% | +$668K | ﹤0.01% | 1926 |
|
|
2023
Q1 | $984K | Buy |
603,894
+105,400
| +21% | +$172K | ﹤0.01% | 2487 |
|
|
2022
Q4 | $663K | Sell |
498,494
-51,200
| -9% | -$68.1K | ﹤0.01% | 2772 |
|
|
2022
Q3 | $858K | Sell |
549,694
-94,000
| -15% | -$147K | ﹤0.01% | 2589 |
|
|
2022
Q2 | $991K | Sell |
643,694
-49,300
| -7% | -$75.9K | ﹤0.01% | 2728 |
|
|
2022
Q1 | $1.77M | Sell |
692,994
-187,200
| -21% | -$479K | ﹤0.01% | 2320 |
|
|
2021
Q4 | $2.58M | Buy |
880,194
+738,182
| +520% | +$2.16M | ﹤0.01% | 1953 |
|
|
2021
Q3 | $348K | Sell |
142,012
-1,094,583
| -89% | -$2.68M | ﹤0.01% | 3030 |
|
|
2021
Q2 | $5.03M | Buy |
1,236,595
+178,932
| +17% | +$728K | 0.01% | 1636 |
|
|
2021
Q1 | $4.77M | Buy |
1,057,663
+955,314
| +933% | +$4.31M | 0.01% | 1676 |
|
|
2020
Q4 | $504K | Buy |
102,349
+37,254
| +57% | +$183K | ﹤0.01% | 2811 |
|
|
2020
Q3 | $386K | Sell |
65,095
-39,905
| -38% | -$237K | ﹤0.01% | 2916 |
|
|
2020
Q2 | $279K | Sell |
105,000
-282,516
| -73% | -$751K | ﹤0.01% | 3065 |
|
|
2020
Q1 | $756K | Buy |
+387,516
| New | +$756K | ﹤0.01% | 2567 |
|
|
2019
Q3 | – | Sell |
-19,700
| Closed | -$225K | – | 3752 |
|
|
2019
Q2 | $225K | Buy |
+19,700
| New | +$225K | ﹤0.01% | 3274 |
|